• 제목/요약/키워드: Thrombin time

검색결과 122건 처리시간 0.03초

Study on a Binder by Using Porcine Blood Plasma Transglutaminase, Thrombin and Fibrinogen

  • Tsai, Chong-Ming;Tseng, Tsai-Fuh;Yang, Jeng-Huh;Chen, Ming-Tsao
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제19권1호
    • /
    • pp.137-143
    • /
    • 2006
  • The purpose of this study was to prepare a binder containing porcine blood transglutaminase (TGase), thrombin and fibrinogen. Extracted TGase, thrombin and fibrinogen were used alone or mixed with different proportions of their volume (v/v/v) by nine combinations as follows were 0.5:1:15, 0.5:1:20, 0.5:1:25, 1:1:15, 1:1:20, 1:1:25, 1.5:1:15, 1.5:1:20 and 1.5:1:25, respectively. Five ml of each combination were mixed with 0.6 ml of 0.25 M calcium chloride before experiment. After storage at 4C for 0, 1, 2, 3, 4 and 5 weeks, enzyme activity, total plate count, pH value, and SDS-PAGE of TGase, thrombin and fibrinogen were tested and pH value, clotting time and gel strength of the nine combination binders were determined. The results showed that total plate count of thrombin and pH value of TGase were significantly higher (p<0.05) than in other treatments. SDS-PAGE results showed that purified TGase, thrombin and fibrinogen from porcine blood plasma compared with commercial products (Sigma) had the same band patterns and nine different combination binders had no significant effect. Enzymatic activity of TGase and thrombin decreased as storage time increased. Total plate count of TGase, thrombin and fibrinogen and clotting time of the binder increased as storage time increased. The higher amount of fibrinogen in combinations, the stronger the gel strength.

피브린의 무게측정에 의한 새로운 트롬빈활성측정법 (The Novel Assay Method for Thrombin by Weighing Fibrin Clot)

  • Park, Inshik;Kim, Gi-Nahm
    • 생명과학회지
    • /
    • 제14권3호
    • /
    • pp.441-444
    • /
    • 2004
  • 본 연구는 피브린의 무게를 측정하는 방법에 의하여 간단하고 단순하게 트롬빈활성을 측정하는 방법을 확립하기 위하여 수행되었다. 이 새로운 트롬빈측정 법은 트롬빈이 기질인 피브리노겐과 반응 후 생성된 피브린의 무게를 측정한다. 피브린의 생성은 사용한 트롬빈의 효소활성, 반응온도, 반응시간 및 원심분리의 시간에 의존하였다. 피브린의 생성은 37$^{\circ}C$에서 트롬빈활성이 1.0 unit/ml 이내, 4.0mg/ml의 피브리노겐 농도 및 반응시간이 5분 이내에는 직선적으로 증가하였다. 그리고 생성된 피브린은 3,000$\times$g에서 5분간 원심분리의 경우에 안정하였다. 이 새로운 피브린 측정 법은 트롬빈을 저해하는 천연물질을 탐색하는데 유행하게 사용될 것으로 기대된다.

유전자 재조합에 의해 제조된 하루딘의 항응고 작용 (Evaluation of Anticoagulant Activity of Recombinant Hirudin)

  • 김영식;엄은미;정정숙;정춘식;정기화;손정훈;최의성;이상기
    • Biomolecules & Therapeutics
    • /
    • 제1권2호
    • /
    • pp.166-170
    • /
    • 1993
  • Hirudin is a potent inhibitor of thrombin, which was originally obtained from the medicinal leech (Hirudo medicinalis) Now it is being produced through the recombinant technology on a large scale. Recombinant hirudin has been assayed for the anticoagulant activity by the measurement of clotting time and the inhibition of thrombin actvity using a chromogenic substrate. The assay range of partial thromboplastin time and thrombin time is within $0.2{\sim}1.0 {\mu}g/mι.$ Thrombin time is more sensitive to the measurement of clot. Ex vivo study showed the level of hirudin in rat plasma was highest in 10 min and then it was eliminated slowly. The half-life of r-hirudin was 80~110 min depending on the assay methods. Intraveneous injection of russel viper venom was used for thrombus induction combined with vents cava ligation. Inhibition of venous thrombosis was observed with i.v. hirudin. It was dependent on the concentration of hirudin.

  • PDF

Pharmacokinetic-Pharmacodynamic Modeling of a Direct Thrombin Inhibitor, Argatroban, in Rats

  • Park, Eun-Hye;Shin, Beom-Soo;Yun, Chi-Ho;Lee, Mann-Hyung;Yoo, Sun-Dong
    • Journal of Pharmaceutical Investigation
    • /
    • 제39권5호
    • /
    • pp.373-379
    • /
    • 2009
  • This study was conducted to develop a pharmacokinetic-pharmacodynamic (PK/PD) model of a direct thrombin inhibitor, argatroban to predict the concentration-effect profiles in rats. Argatroban was i.v. injected to rats at 0. 2, 0.8 and 3.2 mg/kg doses (n = 4-5 per dose), and plasma drug levels were determined by a validated LC/MS/MS assay. The pharmacokinetics of argatroban was linear over the i.v. dose range studied. The thrombin time (TT) and the activated partial thromboplastin time (aPTT) were measured in rat plasma and they were found to linearly increase with increasing the dose. A 2-compartment pharmacokinetic model linked with an indirect response pharmacodynamic model was successfully utilized to evaluate the drug concentration-response relationship.

The Anticoagulant Fraction from the Leaves of Diospyros Kaki L. Has an Antithrombotic Activity

  • Sa You Seon;Kim Soo-Jin;Choi Hye-Seon
    • Archives of Pharmacal Research
    • /
    • 제28권6호
    • /
    • pp.667-674
    • /
    • 2005
  • The leaves of Persimmon (Diospyros kaki L.) has long been used for tea in Korea since it was thought to be effective against hypertension. An anticoagulant fraction was purified through gel filtration G-100, hydrophobic, gel filtration G-150, and FPLC, Phenyl superpose column chromatographies. The purified fraction was homogenous and its Mr was estimated 10,000 Da by gel filtration and SDS-PAGE. The purified fraction was sensitive to treatment of subtilisin B, but not to heat and its activity was not changed after periodate oxidation, indicating that the activity was not due to carbohydrates. It delayed thrombin time (TT), activated partial thromboplastin time (APTT), and prothrombin time (PT) using human plasma. TT was more sensitive than APTT and PT, suggesting that the anticoagulant activity may be caused by a degradation or a defect of fibrin or thrombin. It did not cause the hydrolysis of fibrin after incubation. However, it inhibited thrombin-catalyzed fibrin formation with a competitive inhibition pattern. These results indicate that it may be an antithrombotic agent and that it is bound to fibrinogen binding sites of thrombin.

약용 및 야생식물로부터 트롬빈 저해물질의 탐색 (Screening of Thrombin Inhibitors from Medicinal and Wild Plants)

  • 권윤숙;김영숙;권하영;권기석;김경재;권정숙;손건호;손호용
    • 생약학회지
    • /
    • 제35권1호통권136호
    • /
    • pp.52-61
    • /
    • 2004
  • Inhibitory activities of 264 methanol extracts, which were prepared from different parts of 210 kinds of wild and medicinal plants, against human thrombin were evaluated. Based on the anti-coagulation activity determined by thrombin time and activated partial thromboplastin time, the 14 extracts were screened. The fibrinolytic activity, heat stability and inhibition of other proteolytic digestive enzymes, such as pepsin, papain, trypsin and chymotrypsin, of the 14 extracts were further determined, and Ginko biloba (herba), Ephedra sinica (radix), Reynoutria elliptica (herba), Amomum tsao-ko Crevost (fructus), and Magnolia officinalis Rehd. et Wils (bark) were finally selected as possible plant sources for anti-thrombosis agent. These results suggested that medicinal and wild plants could be the potential source of thrombin inhibitor.

Stimulation of an Esterase Activity of Thrombin by Dequalinium and Its Relationship with Blood Coagulation

  • Paik, Seung-R.;Kim, Do-Hyung;Chang, Chung-Soon
    • BMB Reports
    • /
    • 제29권3호
    • /
    • pp.225-229
    • /
    • 1996
  • Effects on thrombin by an amphipathic cation, dequalinium, which has been recognized as an anticarcinoma agent were investigated with small chromogenic substrates such as Na-benzoyl-DL-argininep-nitroanilide (BApNA), H-D-phenylalanyl-L-pipecoyl-L-arginine-p-nitroanilide (S-2238), and Na-p-tosyl-L-arginine methyl ester (TAME). Among them, only TAME hydrolysis due to an esterase activity of the enzyme was significantly activated to 81% at 20 ${\mu}M$ dequalinium in the absence of NaCl. This stimulation became even higher in the presence of 0.2 M NaCl to 3.5-fold at 60 ${\mu}M$ dequalinium. This specific activation of thrombin was well correlated with the results of in vitro coagulation tests measuring the activated partial thromboplastin time (APTT) and the prothrombin time (PT) It is pertinent. therefore, to suggest that the esterase activity should be examined in addition to the effects on 5-2238 hydrolysis when especially any regulators not directed to an active site of thrombin need to be studied. We also expect that dequalinium could be a useful tool for studying structure-function relationship of thrombin and blood coagulation.

  • PDF

창상치유 목적의 혈소판 치료를 위한 Thrombin의 최적 농도 (Optimal Concentration of Thrombin to Activate Platelet for Wound Healing)

  • 엄수진;한승규;전경욱;김우경
    • Archives of Plastic Surgery
    • /
    • 제36권1호
    • /
    • pp.19-23
    • /
    • 2009
  • Purpose: Platelet transplantation is a novel therapeutic strategy for acceleration of wound healing. When applying platelets, efficacy of adding thrombin to stimulate growth factor release from platelets has already been proved. However, no quantitative data of the thrombin treatment has been reported. The purpose of this study was to determine the optimal thrombin concentration to maximize growth factor release of platelets. In particular, this study was designed to quantify levels of platelet derived growth factor(PDGF)-BB, which is a major growth factor contained in the platelets, in vitro. Methods: Fresh platelets were obtained from a blood bank. They were suspended in DMEM/F - 12 and incubated with thrombin of various concentrations. The concentrations of thrombin tested were 0, 6.25, 12.5, 25, 50, 100, 200, and 400 IU/ml. After 30 minutes, 1, 3, 5, and 7 days, the levels of PDGF - BB were measured using enzyme linked immunosorbent assay. Platelets from four donors were included in this study. Each sample was tested in triplicate and the mean value was used as a data for each sample. Results: The addition of thrombin increased the level of PDGF - BB. Increases in storage time of platelets resulted in decreased levels of PDGF - BB. Higher levels of PDGF were detected in consort with increased thrombin concentrations. However, there was no significant difference between samples of 200 and 400 IU/ml concentrations. Conclusion: The results indicate that adding thrombin accelerates the release of growth factors from platelets and the optimal thrombin concentration to maximize this function is 200 IU/ml.

식용 및 약용 산채류로부터 트롬빈 저해물질의 탐색 (Inhibitory Activities of Edible and Medicinal Herbs Against Human Thrombin)

  • 권정숙;권윤숙;김영숙;권기석;진익렬;류기철;손호용
    • 생명과학회지
    • /
    • 제14권3호
    • /
    • pp.509-513
    • /
    • 2004
  • 혈전 관련 질환 예방 및 혈류개선 기능성 식품의 개발을 목표로, 식용 및 약용 산채류 55종의 메탄을 추출물을 조제한 후 트롬빈 저해활성을 검색하였다. 그 결과, 대조군으로 사용된 아스피린보다 우수한 항혈전 활성을 나타내는 붉나무, 사삼, 우산나물, 쥐다래, 참나물, 할미밀망, 큰까치수영, 첫버들 추출물 등 8종을 선별하였으며, aPTT, 혈전 용해활성, 열 안정성, 기타 소화효소 저해활성 등을 평가하며 참나물, 큰까치수영 및 갯버들 추출물을 최종 선별하였다. 참나물의 경우 열안정성이 낮은 반면 소화효소 비저해로 인해 그 이용성이 높으며, 큰 까치수영 및 갯버들의 경우 부분적인 소화효소 저해능이 있으나 우수한 항혈전활성 및 열 안정성을 나타내어 다양한 식품소재로 개발이 가능함을 확인하였다.

유방염에 이환된 젖소에 있어서 혈액 동태학에 관한 연구 (Study on the hemodynamics in cows with naturally mastitis)

  • 허정호;손성기;이주홍;김종수
    • 한국동물위생학회지
    • /
    • 제18권2호
    • /
    • pp.182-188
    • /
    • 1995
  • Hemodynamic values were assessed in cows with naturally mastatis. hemodynamic tests included WBC, RBC, PCV, Hemoglobin, Monocyte, Eosinophil, Neutrophil, Lymphocyte, and prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen, platelet, antithrombin-III, and plasminogen activities. Significant changes were observed in the mean values of most analytses : WBC, monocytes, eosinophil, neutrophil were increased and Iymphocyte were decreased. prothrombin time was increased: activated partial thromboplastin time, thrombin time. increased : activated partial thromboplastin time, thrombin time, fibrinogen concentration, plasminogen activity and platelet concentration were decreased : and RBC, PCV, hemoglobin and antithrombin-III activity were unchanged, compared with normal mean values. Thesse data indicated activation of hemodynamic mechanisms, initiated either directly by bacteria produced endotoxin of secondaly inflammatory mediators produced in response to caused bacteria and naturally acquired mastitis was very similar to the experimental endotoxin-induced mastitis.

  • PDF